Log In
Print this Print this

Vedroprevir (GS-9451)

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionHCV NS3 protease inhibitor
Molecular Target HCV NS3 protease
Mechanism of ActionHCV NS3 protease inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV genotype 1 infection in treatment-naïve patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today